HomeCompareBIESF vs VICI

BIESF vs VICI: Dividend Comparison 2026

BIESF yields 0.15% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VICI wins by $891.2K in total portfolio value
10 years
BIESF
BIESF
● Live price
0.15%
Share price
$32.00
Annual div
$0.05
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$75.0K
Annual income
$32,334.90
Full BIESF calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — BIESF vs VICI

📍 VICI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBIESFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BIESF + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BIESF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BIESF
Annual income on $10K today (after 15% tax)
$12.37/yr
After 10yr DRIP, annual income (after tax)
$27,484.67/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, VICI beats the other by $488,785.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BIESF + VICI for your $10,000?

BIESF: 50%VICI: 50%
100% VICI50/50100% BIESF
Portfolio after 10yr
$520.6K
Annual income
$319,855.51/yr
Blended yield
61.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

BIESF
No analyst data
Altman Z
2.2
Piotroski
4/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BIESF buys
0
VICI buys
0
No recent congressional trades found for BIESF or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBIESFVICI
Forward yield0.15%6.52%
Annual dividend / share$0.05$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%44.3%
Portfolio after 10y$75.0K$966.2K
Annual income after 10y$32,334.90$607,376.13
Total dividends collected$52.6K$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: BIESF vs VICI ($10,000, DRIP)

YearBIESF PortfolioBIESF Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$10,729$29.12$11,361$941.49$632.00VICI
2$11,539$58.39$13,320$1,481.32$1.8KVICI
3$12,464$117.38$16,284$2,405.01$3.8KVICI
4$13,573$236.99$21,040$4,071.78$7.5KVICI
5$15,006$482.41$29,209$7,285.49$14.2KVICI
6$17,053$996.86$44,443$14,006.51$27.4KVICI
7$20,364$2,117.50$75,822$29,512.55$55.5KVICI
8$26,516$4,726.47$148,733$69,726.75$122.2KVICI
9$39,876$11,503.41$344,394$189,413.75$304.5KVICI
10$75,002$32,334.90$966,234$607,376.13$891.2KVICI

BIESF vs VICI: Complete Analysis 2026

BIESFStock

Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis; and Haemonine for haemophilia B acute therapy and prophylaxis. The company's products also comprise Cytotect CP biotest for cytomegalovirus infections; Fovepta for hepatitis B prophylaxis in neonates; Hepatect for prophylaxis of hepatitis B reinfection; Intratect and IgG Next Genration for primary immune and secondary antibody deficiency syndromes and autoimmune diseases, as well as neurological indications; Varitect for the treatment of varicella zoster virus infections; and Zutectra for hepatitis B re-infection prophylaxis after liver transplantation. In addition, it provides Albiomin and Biseko to restore and maintain circulating blood volume; Cofact for the treatment of clotting factors deficiency; Fibrinogen to treat congenital fibrinogen deficiency; Trimodulin for the community-acquired pneumonia and COVID-19; and Pentaglobin to treat bacterial infections. The company was formerly known as Biotest Serum-Institut GmbH and changed its name to Biotest Aktiengesellschaft in 1986. The company was founded in 1946 and is headquartered in Dreieich, Germany. As of January 21, 2022, Biotest Aktiengesellschaft operates as a subsidiary of Grifols, S.A.

Full BIESF Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this BIESF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BIESF vs SCHDBIESF vs JEPIBIESF vs OBIESF vs KOBIESF vs MAINBIESF vs NNNBIESF vs EPRTBIESF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.